Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.

Author
Keskin, Dilek
Sadri, Sevıl
Eskazan, AHMET EMRE
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/82793
https://doi.org/10.2147/dddt.s85050
Collections